Healthcare provider profile · identity verified

Aftab A Khan, M.D.

Internal Medicine · DAVENPORT, FL · NPI 1699851584

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	728	253
Lisinopril	Lisinopril	418	154
Amlodipine Besylate	Amlodipine Besylate	357	138
Metformin Hcl	Metformin Hcl	347	120
Levothyroxine Sodium	Levothyroxine Sodium	340	107
Losartan Potassium	Losartan Potassium	328	124
Gabapentin	Gabapentin	287	113
Metoprolol Tartrate	Metoprolol Tartrate	244	83
Furosemide	Furosemide	180	71
Glimepiride	Glimepiride	160	55
Omeprazole	Omeprazole	160	67
Rosuvastatin Calcium	Rosuvastatin Calcium	157	55
Alendronate Sodium	Alendronate Sodium	156	68
Potassium Chloride	Potassium Chloride	137	52
Montelukast Sodium	Montelukast Sodium	133	45
Hydrochlorothiazide	Hydrochlorothiazide	127	44
Simvastatin	Simvastatin	125	43
Albuterol Sulfate Hfa	Albuterol Sulfate	117	58
Fluticasone Propionate	Fluticasone Propionate	116	67
Ezetimibe	Ezetimibe	115	39
Sertraline Hcl	Sertraline Hcl	114	39
Tamsulosin Hcl	Tamsulosin Hcl	105	34
Clopidogrel	Clopidogrel Bisulfate	100	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	100	29
Metoprolol Succinate	Metoprolol Succinate	100	36
Eliquis	Apixaban	98	24
Famotidine	Famotidine	96	42
Pravastatin Sodium	Pravastatin Sodium	95	31
Allopurinol	Allopurinol	93	27
Ozempic	Semaglutide	90	24
Trazodone Hcl	Trazodone Hcl	90	34
Baclofen	Baclofen	88	52
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	34
Meloxicam	Meloxicam	88	39
Alprazolam	Alprazolam	86	23
Pantoprazole Sodium	Pantoprazole Sodium	86	30
Carvedilol	Carvedilol	81	29
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	75	58
Methylprednisolone	Methylprednisolone	74	54
Glipizide	Glipizide	59	23
Jardiance	Empagliflozin	58	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	56	19
Diclofenac Sodium	Diclofenac Sodium	55	23
Azithromycin	Azithromycin	50	44
Pioglitazone Hcl	Pioglitazone Hcl	50	18
Escitalopram Oxalate	Escitalopram Oxalate	48	15
Clonidine Hcl	Clonidine Hcl	42	17
Fenofibrate	Fenofibrate	42	16
Hydralazine Hcl	Hydralazine Hcl	42	20
Atenolol	Atenolol	40	16
Tresiba Flextouch U-200	Insulin Degludec	40	suppressed
Xarelto	Rivaroxaban	39	11
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Finasteride	Finasteride	34	suppressed
Prednisone	Prednisone	33	28
Lorazepam	Lorazepam	32	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	16
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Sucralfate	Sucralfate	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	18
Trulicity	Dulaglutide	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nitroglycerin	Nitroglycerin	24	12
Novolog Flexpen	Insulin Aspart	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Temazepam	Temazepam	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Jantoven	Warfarin Sodium	23	suppressed
Mupirocin	Mupirocin	22	17
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Lovastatin	Lovastatin	21	suppressed
Naproxen	Naproxen	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	11
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	16
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Ondansetron Odt	Ondansetron	18	14
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	11
Januvia	Sitagliptin Phosphate	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Methimazole	Methimazole	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Invokana	Canagliflozin	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Metolazone	Metolazone	13	suppressed
Metronidazole	Metronidazole	13	13
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	13	11
Oxcarbazepine	Oxcarbazepine	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error